1 янв 1998 г. - Trastuzumab
Описание:
For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.
Добавлено на ленту времени:
Дата: